Round Table

Attenzione: apre in una nuova finestra.

Round Table

supported by Nycomed-Takeda

Sunday, September 2, 10:15 am - 12:00 pm
Long-term Acid Suppression with PPIs: Current Knowledge and Open Questions
Chair: C. Scarpignato (Parma)

Welcome and Introduction. C. Scarpignato (Parma)

  • Long-term PPIs: Is There Any Safety Concern? R.H. Hunt (Hamilton)

- Is PPI-induced hypergastrinemia safe in the long-term?
- Is there any clinically significant effect of PPIs on electrolyte (Mg, Ca and Fe) and vitamins (B12) absorption?
- Are GI and non GI infections more frequent in PPI users?

  • Drug-interactions with PPIs: Are They Clinically Relevant? V. Savarino (Genoa)

- Is there any effect of PPIs on drug absorption?
- Do PPIs affect the efficacy of anticoagulant and antiplatelet therapy?
- Is the interaction potential of the different PPIs different?

  • Generic Formulations of PPIs: Are They Similarly Effective? C. Blandizzi (Pisa)

- Why do we need generic formulations?
- How the bioequivalence of generic PPIs should be ascertained?
- Do the antisecretory effect of generic PPIs overlap that of the branded formulations?

Panel Discussion & Questions from the Floor

Closing Remarks. C. Scarpignato (Parma)